| Entry |
|
|---|
| Name |
|
|---|
| Formula |
C8H16O2
|
|---|
| Exact mass |
144.115
|
|---|
| Mol weight |
144.2114
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Reaction |
|
|---|
| Pathway |
| map00982 | Drug metabolism - cytochrome P450 |
|
|---|
| Enzyme |
1.14.13.- 1.14.14.-
|
|---|
| Brite |
Target-based classification of compounds [BR:br08010]
Enzymes
Transferases
4-aminobutyrate aminotransferase
C07185 Valproic acid
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N03 ANTIEPILEPTICS
N03A ANTIEPILEPTICS
N03AG Fatty acid derivatives
N03AG01 Valproic acid
D00399 Valproic acid (USP) <US>
USP drug classification [BR:br08302]
Anticonvulsants
Anticonvulsants, Other
Multiple MOA
Valproic Acid
D00399 Valproic acid (USP)
Antimigraine Agents
Prophylactic
Valproic Acid
D00399 Valproic acid (USP)
Bipolar Agents
Mood Stabilizers
Valproic Acid
D00399 Valproic acid (USP)
Target-based classification of drugs [BR:br08310]
Ion channels
Voltage-gated ion channels
Calcium channels
CACNA1-T
D00399 Valproic acid (USP) <US>
Enzymes
Oxidoreductases (EC1)
Dehydrogenases
SSADH
D00399 Valproic acid (USP) <US>
Transferases (EC2)
Aminotransferase
ABAT
D00399 Valproic acid (USP) <US>
Lyases (EC4)
Carboxy-lyases
GAD
D00399 Valproic acid (USP) <US>
Pharmacogenomic biomarkers [br08341.html]
Polymorphisms and mutations affecting drug response
D00399
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 10
1 C1c C 25.4573 -18.6784
2 C1b C 25.4573 -17.3002
3 C1b C 24.2485 -19.3967
4 C6a C 26.6604 -19.3967
5 C1b C 24.2427 -16.5935
6 C1b C 23.0396 -18.6784
7 O6a O 26.6604 -20.7925
8 O6a O 27.8692 -18.6784
9 C1a C 23.0339 -17.3002
10 C1a C 21.8367 -19.3967
BOND 9
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 1
5 3 6 1
6 4 7 1
7 4 8 2
8 5 9 1
9 6 10 1
|
|---|
